The significance of haemochromatosis gene mutations in the general population: implications for screening.
about
Pathophysiology of hereditary hemochromatosisCommon variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetranceHepatocellular carcinoma and the penetrance of HFE C282Y mutations: a cross sectional studyHemochromatosis gene in leukemia and lymphomaGenetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutationModifying factors of the HFE hemochromatosis phenotypeGenetic susceptibility to lead poisoningIncidence of liver disease in people with HFE mutations.Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins.Nucleotide-binding oligomerization domain containing 1 (NOD1) haplotypes and single nucleotide polymorphisms modify susceptibility to inflammatory bowel diseases in a New Zealand caucasian population: a case-control study.HFE gene mutations increase the risk of coronary heart disease in women.Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH).IMPDH1 promoter mutations in a patient exhibiting azathioprine resistance.Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis.Public health aspects of genetic screening for hereditary haemochromatosis in Australia.Hereditary hemochromatosis: perspectives of public health, medical genetics, and primary care.Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men.Mutations in the hereditary haemochromatosis gene HFE in professional endurance athletes.Population screening for haemochromatosis.HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosisVariable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy.Iron nutrition in the UK: getting the balance right.A diagnostic approach to hemochromatosisHaplotype Analysis of Hemochromatosis Gene Polymorphisms in Chronic Hepatitis C Virus Infection: A Case Control Study.Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases riskHFE gene variants affect iron in the brain.Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes.Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome.Tumor necrosis factor receptor superfamily, member 1B haplotypes increase or decrease the risk of inflammatory bowel diseases in a New Zealand caucasian population.Screening in liver disease.HFE based re-evaluation of heterozygous hemochromatosis.Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals.Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.Opinion of the Scientific Panel on Dietetic products, nutrition and allergies [NDA] related to the Tolerable Upper Intake Level of IronThe role of HFE genotype in macrophage phenotype.Using iron studies to predict HFE mutations in New Zealand: implications for laboratory testing.Influence of haemochromatosis gene mutations on treatment outcomes in patients with hepatitis C.
P2860
Q24654441-8D56ED56-3881-4D78-B017-3A984B601C2AQ24655382-263814F9-39AD-4A39-83C4-237B11900497Q24811285-3D77778D-230C-4D23-A303-5975387CDEEDQ28217088-7D47BE35-E7AE-4D4C-B621-A8CEE04C89BAQ28301995-A5C121C0-0354-4809-93E0-6D04A37394D7Q28303528-6A3E39B8-19DA-4CB4-A0B0-723EF9F4FDBAQ28391955-3FE0C4B7-CBB1-42BD-B191-B53D91CEBAF8Q30652113-983A8A8B-8E9C-4C47-B0E2-1514FF7FF97EQ30852006-5C7584EA-43FE-4942-BDD7-0893B33CBA0EQ33423258-7C560D88-828D-41E9-9EF1-D9A0871283D2Q34098546-CBF42592-254D-4DDB-AFF8-DE0001E21ACEQ34310530-DCB70BC8-AED4-407F-A979-5C5F16B7EBE7Q34483947-2EFD8EF4-A8C8-4AE5-A4F4-55006A55EEE2Q34568904-5DB7C8F4-AB5C-4D1E-B481-3FCBB6CAD147Q34791748-E607F331-AD63-4975-A927-0FFEADC9546AQ35046454-193EFF30-1E0F-432E-8449-9A3133E2E725Q35051943-CC45F9F7-2871-4FCF-B2BB-A6044F68D1D0Q35057484-2FD4EA13-ED5F-481B-BCA6-1D5074B0C47AQ35329531-5D44DCC9-38AE-4353-90A3-7CF5335DB777Q35359412-A1007963-9722-425F-9AEE-9A8E21155E96Q35361480-47C13B1A-C0E7-49BF-9FE2-5B0C6197A9DBQ35363883-71080D82-E19F-44F2-8DD3-626B3F264898Q35376979-1B70CC3D-C331-40FE-8A42-2A916B1BE83BQ36098179-A72512D3-5EE0-4D33-8557-8C4A8C213263Q36586530-64E00BC5-10DD-4074-9897-6B041792B5ECQ37213062-75E4791F-4D75-4C34-B13D-D9B4019B17DAQ37335107-B83F1786-C8F9-42F8-81C4-B86F6979DF4EQ37846398-544E96FE-680A-4E31-A21B-252E9E61076AQ38627193-413B19E2-5848-499C-AC53-6ED86D5226D5Q38644627-5499C06D-D2C5-4D4B-AC35-0DD82D78F179Q40800759-D8360716-A795-4AFF-8706-78092A5E212BQ42105725-56E4CEFB-4641-4C62-A950-7777AACFAF18Q42726447-42AF012C-18AE-402E-AB28-0A6792949E28Q44124692-F2B2DEA0-A0DB-48D9-BBBD-BF2355C54B15Q45175510-2B1BA9C6-6CFF-4E6E-8D73-BD89EEC79672Q46734844-F162863E-B0EB-4008-9907-CF3CA7E5AD3FQ47143438-C65470CE-001B-40CC-9486-9F1514AE8618Q47825602-D32B52BA-C9C4-4FD2-9B8C-00CBF08C7582Q48030548-D28A70E2-D046-4F46-9682-75629C5F53E3Q49281919-531EA0D9-E00B-402D-B921-7F6A11B01AEC
P2860
The significance of haemochromatosis gene mutations in the general population: implications for screening.
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The significance of haemochrom ...... n: implications for screening.
@ast
The significance of haemochrom ...... n: implications for screening.
@en
type
label
The significance of haemochrom ...... n: implications for screening.
@ast
The significance of haemochrom ...... n: implications for screening.
@en
prefLabel
The significance of haemochrom ...... n: implications for screening.
@ast
The significance of haemochrom ...... n: implications for screening.
@en
P2093
P2860
P356
P1433
P1476
The significance of haemochrom ...... n: implications for screening.
@en
P2093
Chapman BA
Chapman TM
Collett JA
Frampton CM
Walmsley TA
P2860
P304
P356
10.1136/GUT.43.6.830
P407
P577
1998-12-01T00:00:00Z